WARPNINE is an independent, not-for-profit and clinical trial sponsor focused on accelerating access to innovative treatments for rare and hard-to-treat cancers. By challenging traditional models, WARPNINE is funding and delivering patient-first clinical trials faster, bringing new hope to those who need it most, when they need it most.